DDI-DrugBank.d624.s0 >> In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. >> 23-26,45-48,69-80,83-91,109-123,134-148,157-184,201-215
DDI-DrugBank.d624.s1 >> Concurrent and/or sequential use of TOBI with other drugs with neurotoxic or ototoxic potential should be avoided. >> 36-39
DDI-DrugBank.d624.s2 >> Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. >> 5-13,27-40,63-72
DDI-DrugBank.d624.s3 >> TOBI should not be administered concomitantly with ethacrynic acid, furosemide, urea, or mannitol. >> 0-3,51-65,68-77,80-83,89-96
